FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1196-1198 April 22, 1993 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: The Coalition of Healthcare Communicators takes exception to the article by Bero et al (Oct. 15 issue).¹ Their research seems to be centered on the supposition of some in academia today that if industry is involved it must be a bad thing. The authors use arbitrary measures to judge the purity of editorial material generated by seminars and symposiums funded by the pharmaceutical industry. For example, readers are asked to accept their judgment of what is a "misleading title," with only one debatable example provided. It is also important to note that the Accreditation Council for Continuing . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Brodkey, A. C. (2005). The Role of the Pharmaceutical Industry in Teaching Psychopharmacology: A Growing Problem. Acad. Psychiatry 29: 222-229 [Abstract] [Full Text]  
• Lexchin, J., Bero, L. A, Djulbegovic, B., Clark, O. (2003). Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326: 1167-1170 [Abstract] [Full Text]